Boundless Bio (BOLD) - Analyst Comments

Boundless Bio (BOLD) – Analyst Comments

Oct 7, 2019 07:19 AM Mizuho Securities Reiterates Buy Rating on Audentes Therapeutics (BOLD) Following Updated Data
Sep 3, 2019 07:58 AM Audentes Therapeutics (BOLD) PT Raised to $50 at Chardan Capital Markets
Jul 29, 2019 06:58 AM
Apr 26, 2019 06:01 AM
Feb 24, 2019 09:23 PM
Nov 26, 2018 03:52 AM
Aug 22, 2018 06:34 AM
Aug 21, 2018 05:52 AM
Aug 8, 2018 05:03 AM
Jun 26, 2018 04:54 AM
Jun 19, 2018 01:17 PM
May 21, 2018 06:42 AM
Feb 12, 2018 04:05 PM
Feb 2, 2018 07:01 AM
Jan 4, 2018 01:04 PM
Dec 12, 2017 04:26 PM
Dec 4, 2017 04:31 PM
Oct 16, 2017 08:20 AM
Sep 22, 2017 08:56 AM
Aug 15, 2016 07:31 AM
Aug 15, 2016 07:14 AM